Clinical Trial Update: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, placebo-controlled study evaluating certolizumab pegol in combination with methotrexate for early active rheumatoid arthritis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: UCB Pharma SA | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-09-22